According to Fortune Business Insights, the global diabetes treatment devices market was valued at USD 10.83 billion in 2018 and is projected to reach USD 22.83 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period. In 2018, North America dominated the market, holding a 40.44% share.
